Hemogenyx Pharmaceuticals PLC Director/PDMR Shareholding (5133E)
12 February 2018 - 6:00PM
UK Regulatory
TIDMHEMO
RNS Number : 5133E
Hemogenyx Pharmaceuticals PLC
12 February 2018
Hemogenyx Pharmaceuticals Plc
("Hemogenyx" or the "Company")
Director / PDMR Shareholding
Hemogenyx Pharmaceuticals Plc (LSE: HEMO), the biotechnology
company developing novel therapies to transform bone marrow and
blood stem cell transplantation, announces that it has been advised
that on 9 February 2018 Adrian Beeston, Non-Executive Director,
purchased 200,000 ordinary shares of GBP0.01 each in the Company
("Ordinary Shares") at a price of 2.1p per share. Following this
transaction Mr Beeston now has an interest in 6,331,969 Ordinary
Shares, representing approximately 1.78 per cent. of the Company's
issued share capital.
The Notification of Dealing Form provided in accordance with the
requirements of MAR in relation to the transactions listed above
are set out below:
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1 Details of the person discharging managerial
responsibilities / person closely associated
---- -----------------------------------------------------------------
a) Name Adrian Beeston
---- ------------------------------ ---------------------------------
2 Reason for the notification
---- -----------------------------------------------------------------
a) Position/status Non-executive Director
---- ------------------------------ ---------------------------------
b) Initial notification Initial notification
/Amendment
---- ------------------------------ ---------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
---- -----------------------------------------------------------------
a) Name Hemogenyx Pharmaceuticals
Plc
---- ------------------------------ ---------------------------------
b) LEI n/a
---- ------------------------------ ---------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
---- -----------------------------------------------------------------
a) Description of Ordinary shares of GBP0.01
the financial each
instrument, type
of instrument
----
Identification ISIN GB00BYX3WZ24
code
b) Nature of the Purchase of Ordinary Shares
transaction
---- ------------------------------ ---------------------------------
c) Price(s) and volume(s)
---- -------------- --------------
Price(s) Volume(s)
---- -------------- --------------
2.1p 200,000
-------------- --------------
d) Aggregated information
----
- Aggregated volume N/A - single transaction
- Price
e) Date of the transaction 9 February 2018
---- ------------------------------ ---------------------------------
f) Place of the transaction London Stock Exchange
---- ------------------------------ ---------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBIGDDDDGBGIC
(END) Dow Jones Newswires
February 12, 2018 02:00 ET (07:00 GMT)
Hemogenyx Pharmaceuticals (LSE:HEMO)
Historical Stock Chart
From Apr 2024 to May 2024
Hemogenyx Pharmaceuticals (LSE:HEMO)
Historical Stock Chart
From May 2023 to May 2024